Supply chain: price cuts moderating but damage done

shopping pharmacy shelf selection
On 1 April a number of large volume drugs managed to avoid a sizable price cut, however the pharmaceutical supply chain has already suffered serious damage says Bruce Annabel. The principle reason for the reduced level of medicines experiencing price cuts was that certain drugs were excluded this time thanks to Government raising the WADP

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Spotlight on 'beautiful but deadly' diseases
Next Censure over experimental use of drug